![Peter Pechan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Peter Pechan
Anciens postes connus de Peter Pechan
Sociétés | Poste | Début | Fin |
---|---|---|---|
LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | 19/05/2021 | 01/12/2021 |
Formation de Peter Pechan
Eberhard Karls Universität Tübingen | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 2 |
Allemagne | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
LogicBio Therapeutics, Inc.
![]() LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Bourse
- Insiders
- Peter Pechan
- Expérience